Welcome to LookChem.com Sign In|Join Free
  • or
1H-Indole-4-carboxamide, 6-bromo-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1R)-1-methylpropyl]is a complex organic compound characterized by an indole ring connected to a carboxamide group and a bromo-substituted pyridine ring. It also features various methyl and propyl substituents, which may contribute to its potential biological activity. Further research and analysis are required to fully understand its properties and possible applications.

1346574-55-7

Post Buying Request

1346574-55-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1346574-55-7 Usage

Uses

Used in Pharmaceutical Industry:
1H-Indole-4-carboxamide, 6-bromo-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1R)-1-methylpropyl]is used as a potential pharmaceutical candidate for [specific application reason] due to its unique structural features and potential biological activity.
Used in Chemical Research:
1H-Indole-4-carboxamide, 6-bromo-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1R)-1-methylpropyl]is used as a subject of chemical research for [reason related to its structure or potential properties], contributing to the advancement of knowledge in organic chemistry and related fields.

Check Digit Verification of cas no

The CAS Registry Mumber 1346574-55-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,5,7 and 4 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1346574-55:
(9*1)+(8*3)+(7*4)+(6*6)+(5*5)+(4*7)+(3*4)+(2*5)+(1*5)=177
177 % 10 = 7
So 1346574-55-7 is a valid CAS Registry Number.

1346574-55-7Relevant academic research and scientific papers

METHOD OF TREATMENT

-

, (2014/09/29)

The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1346574-55-7